nach oben

Erschienen in:

01.01.2013 | Biological Psychiatry - Review article

Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder

Erschienen in: Journal of Neural Transmission | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

In 2000, Gorman et al. published a widely acknowledged revised version of their 1989 neuroanatomical hypothesis of panic disorder (PD). Herein, a ‘fear network’ was suggested to mediate fear- and anxiety-related responses: panic attacks result from a dysfunctional coordination of ‘upstream’ (cortical) and ‘downstream’ (brainstem) sensory information leading to heightened amygdala activity with subsequent behavioral, autonomic and neuroendocrine activation. Given the emergence of novel imaging methods such as fMRI and the publication of numerous neuroimaging studies regarding PD since 2000, a comprehensive literature search was performed regarding structural (CT, MRI), metabolic (PET, SPECT, MRS) and functional (fMRI, NIRS, EEG) studies on PD, which will be reviewed and critically discussed in relation to the neuroanatomical hypothesis of PD. Recent findings support structural and functional alterations in limbic and cortical structures in PD. Novel insights regarding structural volume increase or reduction, hyper- or hypoactivity, laterality and task-specificity of neural activation patterns emerged. The assumption of a generally hyperactive amygdala in PD seems to apply more to state than trait characteristics of PD, and involvement of further areas in the fear circuit, such as anterior cingulate and insula, is suggested. Furthermore, genetic risk variants have been proposed to partly drive fear network activity. Thus, the present state of knowledge generally supports limbic and cortical prefrontal involvement as originally proposed in the neuroanatomical hypothesis. Some modifications might be suggested regarding a potential extension of the fear circuit, genetic factors shaping neural network activity and neuroanatomically informed clinical subtypes of PD potentially guiding future treatment decisions.

As this study—apart from abstract and figures—is only available in Chinese, methodology could not be sufficiently assessed. Therefore, it is not presented in the tables, but is mentioned for completeness.

Abadie P, Boulenger JP, Benali K, Barré L, Zarifian E, Baron JC (1999) Relationships between trait and state anxiety and the central benzodiazepine receptor: a PET study. Eur J Neurosci 11:1470–1478PubMedCrossRef

Abbott A (2007) Model behaviour. Nature 450(7166):6–7PubMedCrossRef

Akiyoshi J, Hieda K, Aoki Y, Nagayama H (2003) Frontal brain hypoactivity as a biological substrate of anxiety in patients with panic disorders. Neuropsychobiology 47(3):165–170PubMedCrossRef

Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martinez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacin C, Romera B, Taub N, Vollebergh WA, EsemeD/Mhedea Investigators ESotEoMDP (2004) Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 420:38–46PubMed

Asami T, Hayano F, Nakamura M, Yamasue H, Uehara K, Otsuka T, Roppongi T, Nihashi N, Inoue T, Hirayasu Y (2008) Anterior cingulate cortex volume reduction in patients with panic disorder. Psychiatry Clin Neurosci 62(3):322–330PubMedCrossRef

Asami T, Yamasue H, Hayano F, Nakamura M, Uehara K, Otsuka T, Roppongi T, Nihashi N, Inoue T, Hirayasu Y (2009) Sexually dimorphic gray matter volume reduction in patients with panic disorder. Psychiatry Res 173(2):128–134PubMedCrossRef

Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, Cassano G, Fineberg N, Gabriels L, Hindmarch I, Kaiya H, Klein DF, Lader M, Lecrubier Y, Lépine JP, Liebowitz MR, Lopez-Ibor JJ, Marazziti D, Miguel EC, Oh KS, Preter M, Rupprecht R, Sato M, Starcevic V, Stein DJ, van Ameringen M, Vega J (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders—first revision. World J Biol Psychiatry 9(4):248–312

Barrett J, Armony JL (2009) Influence of trait anxiety on brain activity during the acquisition and extinction of aversive conditioning. Psychol Med 39(2):255–265PubMedCrossRef

Batelaan N, Smit F, de Graaf R, van Balkom A, Vollebergh W, Beekman A (2007) Economic costs of full-blown and subthreshold panic disorder. J Affect Disord 104(1–3):127–136PubMedCrossRef

Berkowitz RL, Coplan JD, Reddy DP, Gorman JM (2007) The human dimension: how the prefrontal cortex modulates the subcortical fear response. Rev Neurosci 18(3–4):191–207PubMed

Beutel ME, Stark R, Pan H, Silbersweig D, Dietrich S (2010) Changes of brain activation pre- post short-term psychodynamic inpatient psychotherapy: an fMRI study of panic disorder patients. Psychiatry Res 184(2):96–104PubMedCrossRef

Bird CM, Burgess N (2008) The hippocampus and memory: insights from spatial processing. Nat Rev Neurosci 9(3):182–194PubMedCrossRef

Bisaga A, Katz JL, Antonini A, Wright CE, Margouleff C, Gorman JM, Eidelberg D (1998) Cerebral glucose metabolism in women with panic disorder. Am J Psychiatry 155(9):1178–1183PubMed

Boshuisen ML, Ter Horst GJ, Paans AMJ, Reinders AATS, den Boer JA (2002) rCBF differences between panic disorder patients and control subjects during anticipatory anxiety and rest. Biol Psychiatry 52(2):126–135PubMedCrossRef

Brandt CA, Meller J, Keweloh L, Hoschel K, Staedt J, Munz D, Stoppe G (1998) Increased benzodiazepine receptor density in the prefrontal cortex in patients with panic disorder. J Neural Transm 105(10–12):1325–1333PubMedCrossRef

Bremner JD, Innis RB, White T, Fujita M, Silbersweig D, Goddard AW, Staib L, Stern E, Cappiello A, Woods S, Baldwin R, Charney DS (2000) SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry 47(2):96–106PubMedCrossRef

Bystritsky A, Leuchter AF, Vapnik T (1999) EEG abnormalities in nonmedicated panic disorder. J Nerv Ment Dis 187(2):113–114PubMedCrossRef

Bystritsky A, Pontillo D, Powers M, Sabb FW, Craske MG, Bookheimer SY (2001) Functional MRI changes during panic anticipation and imagery exposure. NeuroReport 12(18):3953–3957PubMedCrossRef

Cameron OG, Huang GC, Nichols T, Koeppe RA, Minoshima S, Rose D, Frey KA (2007) Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder. Arch Gen Psychiatry 64(7):793–800PubMedCrossRef

Charney DS (2003) Neuroanatomical circuits modulating fear and anxiety behaviors. Acta Psychiatr Scand 417:38–50CrossRef

Chechko N, Wehrle R, Erhardt A, Holsboer F, Czisch M, Samann PG (2009) Unstable prefrontal response to emotional conflict and activation of lower limbic structures and brainstem in remitted panic disorder. PLoS ONE 4(5):e5537PubMedCrossRef

Crippa JA, Uchida R, Busatto GF, Guimaraes FS, Del-Ben CM, Zuardi AW, Santos AC, Araujo D, McGuire PK, Graeff FG (2004) The size and prevalence of the cavum septum pellucidum are normal in subjects with panic disorder. Braz J Med Biol Res 37(3):371–374PubMedCrossRef

Dager SR, Marro KI, Richards TL, Metzger GD (1994) Preliminary application of magnetic resonance spectroscopy to investigate lactate-induced panic. Am J Psychiatry 151(1):57–63PubMed

Dager SR, Strauss WL, Marro KI, Richards TL, Metzger GD, Artru AA (1995) Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects. Am J Psychiatry 152(5):666–672PubMed

Dager SR, Richards T, Strauss W, Artru A (1997) Single-voxel 1H-MRS investigation of brain metabolic changes during lactate-induced panic. Psychiatry Res 76(2–3):89–99PubMed

Dager SR, Friedman SD, Heide A, Layton ME, Richards T, Artru A, Strauss W, Hayes C, Posse S (1999) Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic. Arch Gen Psychiatry 56(1):70–77PubMedCrossRef

Dantendorfer K, Prayer D, Kramer J, Amering M, Baischer W, Berger P, Schoder M, Steinberger K, Windhaber J, Imhof H, Katschnig H (1996) High frequency of EEG and MRI brain abnormalities in panic disorder. Psychiatry Res 68(1):41–53PubMedCrossRef

Davis M, Walker DL, Miles L, Grillon C (2010) Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35(1):105–135PubMedCrossRef

de Carvalho MR, Dias GP, Cosci F, de-Melo-Neto VL, Bevilaqua MC, Gardino PF, Nardi AE (2010) Current findings of fMRI in panic disorder: contributions for the fear neurocircuitry and CBT effects. Expert Rev Neurother 10(2):291–303PubMedCrossRef

De Cristofaro MT, Sessarego A, Pupi A, Biondi F, Faravelli C (1993) Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: a SPECT study. Biol Psychiatry 33(7):505–512PubMedCrossRef

Dieler AC, Tupak SV, Fallgatter AJ (2012) Functional near-infrared spectroscopy for the assessment of speech related tasks. Brain Lang 121(2):90–109

Domschke K, Zwanzger P (2008) GABAergic and endocannabinoid dysfunciton in anxiety—future therapeutic targets? Curr Pharm Des 14(33):3508–3517

Domschke K, Dannlowski U (2010) Imaging genetics of anxiety disorders. NeuroImage 53(3):822–831PubMedCrossRef

Domschke K, Braun M, Ohrmann P, Suslow T, Kugel H, Bauer J, Hohoff C, Kersting A, Engelien A, Arolt V, Heindel W, Deckert J (2006) Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol 9(3):349–355PubMedCrossRef

Domschke K, Ohrmann P, Braun M, Suslow T, Bauer J, Hohoff C, Kersting A, Engelien A, Arolt V, Heindel W, Deckert J, Kugel H (2008) Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res 163(1):13–20PubMedCrossRef

Domschke K, Stevens S, Pfleiderer B, Gerlach AL (2010) Interoceptive sensitivity in anxiety and anxiety disorders: an overview and integration of neurobiological findings. Clin Psychol Rev 30(1):1–11PubMedCrossRef

Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P, Pedersen A, Bauer J, Suslow T, Kugel H, Heindel W, Baumann C, Klauke B, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P, Rothermundt M, Erhardt A, Binder EB, Holsboer F, Gerlach AL, Kircher T, Lang T, Alpers GW, Strohle A, Fehm L, Gloster AT, Wittchen HU, Arolt V, Pauli P, Hamm A, Deckert J (2011) Neuropeptide S receptor gene—converging evidence for a role in panic disorder. Mol Psychiatry 16(9):938–948PubMedCrossRef

Domschke K, Tidow N, Kuithan H, Schwarte K, Klauke B, Ambrée O, Reif A, Schmidt H, Arolt V, Kersting A, Zwanzger P, Deckert J (2012) Monoamine oxidase A gene DNA hypomethylation—a risk factor for panic disorder? Int J Neuropsychopharmacol (in press)

Dresler T, Ehlis AC, Plichta MM, Richter MM, Jabs B, Lesch KP, Fallgatter AJ (2009) Panic disorder and a possible treatment approach by means of high-frequency rTMS: a case report. World J Biol Psychiatry 10(4):991–997PubMedCrossRef

Dresler T, Hahn T, Plichta MM, Ernst LH, Tupak SV, Ehlis AC, Warrings B, Deckert J, Fallgatter AJ (2011) Neural correlates of spontaneous panic attacks. J Neural Transm 118(2):263–269PubMedCrossRef

Drevets WC, Videen TQ, MacLeod AK, Haller JW, Raichle ME (1992) PET images of blood flow changes during anxiety: correction. Science 256(5064):1696PubMedCrossRef

Engel K, Bandelow B, Gruber O, Wedekind D (2009) Neuroimaging in anxiety disorders. J Neural Transm 116(6):703–716PubMedCrossRef

Eren I, Tukel R, Polat A, Karaman R, Unal S (2002) Evaluation of regional cerebral blood flow changes in panic disorder with Tc99m-HMPAO SPECT. Turk Psikiyatri Derg 13(2):89–97PubMed

Eren I, Tukel R, Polat A, Karaman R, Unal S (2003) Evaluation of regional cerebral blood flow changes in panic disorder with Tc99m-HMPAO SPECT. Psychiatry Res 123(2):135–143PubMedCrossRef

Etkin A (2010) Functional neuroanatomy of anxiety: a neural circuit perspective. Curr Top Behav Neurosci 2:251–277PubMedCrossRef

Etkin A, Egner T, Peraza DM, Kandel ER, Hirsch J (2006) Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron 51(6):871–882 (erratum in Neuron 2006 Dec 21;52(6):1121)PubMedCrossRef

Etkin A, Egner T, Kalisch R (2011) Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn Sci 15(2):85–93

Fava L, Morton J (2009) Causal modeling of panic disorder theories. Clin Psychol Rev 29(7):623–637PubMedCrossRef

Ferrari MC, Busatto GF, McGuire PK, Crippa JA (2008) Structural magnetic resonance imaging in anxiety disorders: an update of research findings. Rev Bras Psiquiatr 30(3):251–264PubMedCrossRef

Fischer H, Andersson JLR, Furmark T, Fredrikson M (1998) Brain correlates of an unexpected panic attack: a human positron emission tomographic study. Neurosci Lett 251(2):137–140PubMedCrossRef

Fontaine R, Breton G, Elie R, Déry R (1987) Neurobiologie des États de panique. Acta Psychiatr Belg 87:607–616PubMed

Fontaine R, Breton G, Dery R, Fontaine S, Elie R (1990) Temporal lobe abnormalities in panic disorder: an MRI study. Biol Psychiatry 27(3):304–310PubMedCrossRef

Fujimura Y, Yasuno F, Farris A, Liow JS, Geraci M, Drevets W, Pine DS, Ghose S, Lerner A, Hargreaves R, Burns HD, Morse C, Pike VW, Innis RB (2009) Decreased neurokinin-1 (substance P) receptor binding in patients with panic disorder: positron emission tomographic study with [18F]SPA-RQ. Biol Psychiatry 66(1):94–97PubMedCrossRef

Fujiwara A, Yoshida T, Otsuka T, Hayano F, Asami T, Narita H, Nakamura M, Inoue T, Hirayasu Y (2011) Midbrain volume increase in patients with panic disorder. Psychiatry Clin Neurosci 65(4):365–373PubMedCrossRef

Garakani A, Mathew SJ, Charney DS (2006) Neurobiology of anxiety disorders and implications for treatment. Mt Sinai J Med 73(7):941–949PubMed

Garakani A, Buchsbaum MS, Newmark RE, Goodman C, Aaronson CJ, Martinez JM, Torosjan Y, Chu KW, Gorman JM (2007) The effect of doxapram on brain imaging in patients with panic disorder. Eur Neuropsychopharmacol 17(10):672–686PubMedCrossRef

Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, Schofield PR, Gordon E, Kemp AH, Williams LM (2009) Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 14(7):681–695PubMedCrossRef

Gloster AT, Wittchen HU, Einsle F, Hofler M, Lang T, Helbig-Lang S, Fydrich T, Fehm L, Hamm AO, Richter J, Alpers GW, Gerlach AL, Strohle A, Kircher T, Deckert J, Zwanzger P, Arolt V (2009) Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. Eur Arch Psychiatry Clin Neurosci 259(Suppl 2):S155–S166PubMedCrossRef

Goddard AW, Mason GF, Appel M, Rothman DL, Gueorguieva R, Behar KL, Krystal JH (2004) Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am J Psychiatry 161(12):2186–2193PubMedCrossRef

Gordon E, Palmer DM, Cooper N (2010) EEG alpha asymmetry in schizophrenia, depression, PTSD, panic disorder, ADHD and conduct disorder. Clin EEG Neurosci 41(4):178–183

Gorman JM, Liebowitz MR, Fyer AJ, Stein J (1989) A neuroanatomical hypothesis for panic disorder. Am J Psychiatry 146(2):148–161PubMed

Gorman JM, Kent JM, Sullivan GM, Coplan JD (2000) Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 157(4):493–505PubMedCrossRef

Graeff FG, Del-Ben CM (2008) Neurobiology of panic disorder: from animal models to brain neuroimaging. Neurosci Biobehav Rev 32(7):1326–1335PubMedCrossRef

Hahn T, Dresler T, Plichta MM, Ehlis AC, Ernst LH, Markulin F, Polak T, Blaimer M, Deckert J, Lesch KP, Jakob PM, Fallgatter AJ (2010) Functional amygdala–hippocampus connectivity during anticipation of aversive events is associated with Gray’s trait “sensitivity to punishment”. Biol Psychiatry 68(5):459–464PubMedCrossRef

Hahn T, Marquand AF, Ehlis AC, Dresler T, Kittel-Schneider S, Jarczok T, Lesch KP, Jakob PM, Mourao-Miranda J, Brammer M, Fallgatter AJ (2011) Integrating neurobiological markers of depression. Arch Gen Psychiatry 68(4):361–368

Ham BJ, Sung Y, Kim N, Kim SJ, Kim JE, Kim DJ, Lee JY, Kim JH, Yoon SJ, Lyoo IK (2007) Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder: a proton magnetic resonance spectroscopy (1H-MRS) study. Prog Neuropsychopharmacol Biol Psychiatry 31(2):403–411PubMedCrossRef

Han DH, Renshaw PF, Dager SR, Chung A, Hwang J, Daniels MA, Lee YS, Lyoo IK (2008) Altered cingulate white matter connectivity in panic disorder patients. J Psychiatr Res 42(5):399–407PubMedCrossRef

Hasler G, Nugent AC, Carlson PJ, Carson RE, Geraci M, Drevets WC (2008) Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography. Arch Gen Psychiatry 65(10):1166–1175PubMedCrossRef

Hasler G, van der Veen JW, Geraci M, Shen J, Pine D, Drevets WC (2009) Prefrontal cortical gamma-aminobutyric acid levels in panic disorder determined by proton magnetic resonance spectroscopy. Biol Psychiatry 65(3):273–275PubMedCrossRef

Hayano F, Nakamura M, Asami T, Uehara K, Yoshida T, Roppongi T, Otsuka T, Inoue T, Hirayasu Y (2009) Smaller amygdala is associated with anxiety in patients with panic disorder. Psychiatry Clin Neurosci 63(3):266–276PubMedCrossRef

Indovina I, Robbins TW, Nunez-Elizalde AO, Dunn BD, Bishop SJ (2011) Fear-conditioning mechanisms associated with trait vulnerability to anxiety in humans. Neuron 69(3):563–571PubMedCrossRef

Jacobi F, Wittchen HU, Holting C, Hofler M, Pfister H, Muller N, Lieb R (2004) Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 34(4):597–611PubMedCrossRef

Kartalci S, Dogan M, Unal S, Ozcan AC, Ozdemir S, Atmaca M (2011) Pituitary volume in patients with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 35(1):203–207PubMedCrossRef

Kaschka W, Feistel H, Ebert D (1995) Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT. J Psychiatr Res 29(5):427–434PubMedCrossRef

Kent JM, Coplan JD, Mawlawi O, Martinez JM, Browne ST, Slifstein M, Martinez D, Abi-Dargham A, Laruelle M, Gorman JM (2005) Prediction of panic response to a respiratory stimulant by reduced orbitofrontal cerebral blood flow in panic disorder. Am J Psychiatry 162(7):1379–1381PubMedCrossRef

Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE (2006) The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 63(4):415–424PubMedCrossRef

Kircanski K, Craske MG, Epstein AM, Wittchen HU (2009) Subtypes of panic attacks: a critical review of the empirical literature. Depress Anxiety 26(10):878–887PubMedCrossRef

Klauke B, Deckert J, Reif A, Pauli P, Domschke K (2010) Life events in panic disorder-an update on “candidate stressors”. Depress Anxiety 27(8):716–730PubMed

Klauke B, Deckert J, Reif A, Pauli P, Zwanzger P, Baumann C, Arolt V, Glockner-Rist A, Domschke K (2011) Serotonin transporter gene and childhood trauma—a G × E effect on anxiety sensitivity. Depress Anxiety 28(12):1048–1057PubMedCrossRef

Klauke B, Deckert J, Zwanzger P, Baumann C, Arolt V, Pauli P, Reif A, Domschke K (in press) Neuropeptide S receptor gene (NPSR) and life events: G × E effects on anxiety sensitivity and its subdimensions. World J Biol Psychiatry. doi:10.3109/15622975.2011.646302

Koh KB, Kang JI, Lee JD, Lee YJ (2010) Shared neural activity in panic disorder and undifferentiated somatoform disorder compared with healthy controls. J Clin Psychiatry 71(12):1576–1581PubMedCrossRef

Kuikka JT, Pitkanen A, Lepola U, Partanen K, Vainio P, Bergstrom KA, Wieler HJ, Kaiser KP, Mittelbach L, Koponen H et al (1995) Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder. Nucl Med Commun 16(4):273–280PubMedCrossRef

Lai CH (2011) Gray matter deficits in panic disorder: a pilot study of meta-analysis. J Clin Psychopharmacol 31(3):287–293PubMedCrossRef

Lai CH, Hsu YY (2011) A subtle grey-matter increase in first-episode, drug-naive major depressive disorder with panic disorder after 6 weeks’ duloxetine therapy. Int J Neuropsychopharmacol 14(2):225–235PubMedCrossRef

Lai CH, Wu YT (2011a) Duloxetine’s modest short-term influences in subcortical structures of first episode drug-naive patients with major depressive disorder and panic disorder. Psychiatry Res 194(2):157–162PubMedCrossRef

Lai CH, Wu YT (2011b) Frontal regional homogeneity increased and temporal regional homogeneity decreased after remission of first-episode drug-naive major depressive disorder with panic disorder patients under duloxetine therapy for 6 weeks. J Affect Disord. doi:10.1016/j.jad.2011.11.004

Lai CH, Hsu YY, Wu YT (2010) First episode drug-naive major depressive disorder with panic disorder: gray matter deficits in limbic and default network structures. Eur Neuropsychopharmacol 20(10):676–682PubMedCrossRef

Lauer CJ, Krieg JC (1992) Sleep electroencephalographic patterns and cranial computed tomography in anxiety disorders. Compr Psychiatry 33(3):213–219PubMedCrossRef

Layton ME, Friedman SD, Dager SR (2001) Brain metabolic changes during lactate-induced panic: effects of gabapentin treatment. Depress Anxiety 14(4):251–254

Lee YS, Hwang J, Kim SJ, Sung YH, Kim J, Sim ME, Bae SC, Kim MJ, Lyoo IK (2006) Decreased blood flow of temporal regions of the brain in subjects with panic disorder. J Psychiatr Res 40(6):528–534PubMedCrossRef

Lepola U, Nousiainen U, Puranen M, Riekkinen P, Rimon R (1990) EEG and CT findings in patients with panic disorder. Biol Psychiatry 28(8):721–727PubMedCrossRef

Lissek S, Rabin S, Heller RE, Lukenbaugh D, Geraci M, Pine DS, Grillon C (2010) Overgeneralization of conditioned fear as a pathogenic marker of panic disorder. Am J Psychiatry 167(1):47–55PubMedCrossRef

Lopes FL, Oliveira MM, Freire RC, Caldirola D, Perna G, Bellodi L, Valença AM, Nascimento I, Piedade RA, Ribeiro P, Zin WA, Nardi AE (2010) Carbon dioxide-induced panic attacks and quantitative electroencephalogram in panic disorder patients. World J Biol Psychiatry 11(2):357–363

Lucey JV, Costa DC, Adshead G, Deahl M, Busatto G, Gacinovic S, Travis M, Pilowsky L, Ell PJ, Marks IM, Kerwin RW (1997a) Brain blood flow in anxiety disorders. OCD, panic disorder with agoraphobia, and post-traumatic stress disorder on 99mTcHMPAO single photon emission tomography (SPET). Br J Psychiatry 171:346–350PubMedCrossRef

Lucey JV, Costa DC, Busatto G, Pilowsky LS, Marks IM, Ell PJ, Kerwin RW (1997b) Caudate regional cerebral blood flow in obsessive–compulsive disorder, panic disorder and healthy controls on single photon emission computerised tomography. Psychiatry Res 74(1):25–33PubMedCrossRef

Maddock RJ, Buonocore MH, Kile SJ, Garrett AS (2003) Brain regions showing increased activation by threat-related words in panic disorder. NeuroReport 14(3):325–328PubMedCrossRef

Maddock RJ, Buonocore MH, Copeland LE, Richards AL (2009) Elevated brain lactate responses to neural activation in panic disorder: a dynamic 1H-MRS study. Mol Psychiatry 14(5):537–545PubMedCrossRef

Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, Jones T, Nutt DJ (1998) Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry 55(8):715–720PubMedCrossRef

Marchand WR, Lee JN, Healy L, Thatcher JW, Rashkin E, Starr J, Hsu E (2009) An fMRI motor activation paradigm demonstrates abnormalities of putamen activation in females with panic disorder. J Affect Disord 116(1–2):121–125PubMedCrossRef

Mark LP, Daniels DL, Naidich TP, Hendrix LE (1995) Limbic connections. AJNR Am J Neuroradiol 16(6):1303–1306PubMed

Maron E, Kuikka JT, Shlik J, Vasar V, Vanninen E, Tiihonen J (2004) Reduced brain serotonin transporter binding in patients with panic disorder. Psychiatry Res 132(2):173–181PubMedCrossRef

Maron E, Nutt DJ, Kuikka J, Tiihonen J (2010) Dopamine transporter binding in females with panic disorder may vary with clinical status. J Psychiatr Res 44(1):56–59PubMedCrossRef

Maron E, Toru I, Hirvonen J, Tuominen L, Lumme V, Vasar V, Shlik J, Nutt DJ, Helin S, Nagren K, Tiihonen J, Hietala J (2011) Gender differences in brain serotonin transporter availability in panic disorder. J Psychopharmacol 25(7):952–959PubMedCrossRef

Martin EI, Ressler KJ, Binder E, Nemeroff CB (2009) The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin North Am 32(3):549–575PubMedCrossRef

Massana G, Gasto C, Junque C, Mercader JM, Gomez B, Massana J, Torres X, Salamero M (2002) Reduced levels of creatine in the right medial temporal lobe region of panic disorder patients detected with (1)H magnetic resonance spectroscopy. NeuroImage 16(3 Pt 1):836–842PubMedCrossRef

Massana G, Serra-Grabulosa JM, Salgado-Pineda P, Gasto C, Junque C, Massana J, Mercader JM (2003a) Parahippocampal gray matter density in panic disorder: a voxel-based morphometric study. Am J Psychiatry 160(3):566–568PubMedCrossRef

Massana G, Serra-Grabulosa JM, Salgado-Pineda P, Gasto C, Junque C, Massana J, Mercader JM, Gomez B, Tobena A, Salamero M (2003b) Amygdalar atrophy in panic disorder patients detected by volumetric magnetic resonance imaging. NeuroImage 19(1):80–90PubMedCrossRef

McNally RJ, Riemann BC, Kim E (1990) Selective processing of threat cues in panic disorder. Behav Res Ther 28(5):407–412PubMedCrossRef

Mendlowicz MV, Stein MB (2000) Quality of life in individuals with anxiety disorders. Am J Psychiat 157(5):669–682PubMedCrossRef

Meyer-Lindenberg A, Weinberger DR (2006) Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7(10):818–827PubMedCrossRef

Michael T, Blechert J, Vriends N, Margraf J, Wilhelm FH (2007) Fear conditioning in panic disorder: enhanced resistance to extinction. J Abnorm Psychol 116(3):612–617PubMedCrossRef

Mobbs D, Petrovic P, Marchant JL, Hassabis D, Weiskopf N, Seymour B, Dolan RJ, Frith CD (2007) When fear is near: threat imminence elicits prefrontal–periaqueductal gray shifts in humans. Science 317(5841):1079–1083PubMedCrossRef

Moratti S, Saugar C, Strange BA (2011) Prefrontal–occipitoparietal coupling underlies late latency human neuronal responses to emotion. J Neurosci 31(47):17278–17286PubMedCrossRef

Nash JR, Sargent PA, Rabiner EA, Hood SD, Argyropoulos SV, Potokar JP, Grasby PM, Nutt DJ (2008) Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. Br J Psychiatry 193(3):229–234PubMedCrossRef

Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA, Eckelman W, Herscovitch P, Charney DS, Drevets WC (2004) Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 24(3):589–591PubMedCrossRef

Nikolaus S, Antke C, Beu M, Muller HW (2010) Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders—results from in vivo imaging studies. Rev Neurosci 21(2):119–139PubMed

Nishimura Y, Tanii H, Fukuda M, Kajiki N, Inoue K, Kaiya H, Nishida A, Okada M, Okazaki Y (2007) Frontal dysfunction during a cognitive task in drug-naive patients with panic disorder as investigated by multi-channel near-infrared spectroscopy imaging. Neurosci Res 59(1):107–112PubMedCrossRef

Nishimura Y, Tanii H, Hara N, Inoue K, Kaiya H, Nishida A, Okada M, Okazaki Y (2009) Relationship between the prefrontal function during a cognitive task and the severity of the symptoms in patients with panic disorder: a multi-channel NIRS study. Psychiatry Res 172(2):168–172PubMedCrossRef

Nordahl TE, Semple WE, Gross M, Mellman TA, Stein MB, Goyer P, King AC, Uhde TW, Cohen RM (1990) Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharmacology 3(4):261–272PubMed

Nordahl TE, Stein MB, Benkelfat C, Semple WE, Andreason P, Zametkin A, Uhde TW, Cohen RM (1998) Regional cerebral metabolic asymmetries replicated in an independent group of patients with panic disorders. Biol Psychiatry 44(10):998–1006PubMedCrossRef

Ohta H, Yamagata B, Tomioka H, Takahashi T, Yano M, Nakagome K, Mimura M (2008) Hypofrontality in panic disorder and major depressive disorder assessed by multi-channel near-infrared spectroscopy. Depress Anxiety 25(12):1053–1059PubMedCrossRef

Ontiveros A, Fontaine R, Breton G, Elie R, Fontaine S, Dery R (1989) Correlation of severity of panic disorder and neuroanatomical changes on magnetic resonance imaging. J Neuropsychiatry Clin Neurosci 1(4):404–408PubMed

Paulus MP, Stein MB (2010) Interoception in anxiety and depression. Brain Struct Funct 214(5–6):451–463PubMedCrossRef

Pessoa L, Adolphs R (2010) Emotion processing and the amygdala: from a ‘low road’ to ‘many roads’ of evaluating biological significance. Nat Rev Neurosci 11(11):773–783

Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR (2005) 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 8(6):828–834PubMedCrossRef

Pfleiderer B, Zinkirciran S, Arolt V, Heindel W, Deckert J, Domschke K (2007) fMRI amygdala activation during a spontaneous panic attack in a patient with panic disorder. World J Biol Psychiatry 8(4):269–272PubMedCrossRef

Pfleiderer B, Zinkirciran S, Michael N, Hohoff C, Kersting A, Arolt V, Deckert J, Domschke K (2010) Altered auditory processing in patients with panic disorder: a pilot study. World J Biol Psychiatry 11(8):945–955PubMedCrossRef

Pilecki B, Arentoft A, McKay D (2011) An evidence-based causal model of panic disorder. J Anxiety Disord 25(3):381–388PubMedCrossRef

Pillay SS, Gruber SA, Rogowska J, Simpson N, Yurgelun-Todd DA (2006) fMRI of fearful facial affect recognition in panic disorder: the cingulate gyrus–amygdala connection. J Affect Disord 94(1–3):173–181PubMedCrossRef

Pillay SS, Rogowska J, Gruber SA, Simpson N, Yurgelun-Todd DA (2007) Recognition of happy facial affect in panic disorder: an fMRI study. J Anxiety Disord 21(3):381–393PubMedCrossRef

Prasko J, Horacek J, Zalesky R, Kopecek M, Novak T, Paskova B, Skrdlantova L, Belohlavek O, Hoschl C (2004) The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinol Lett 25(5):340–348PubMed

Protopopescu X, Pan H, Tuescher O, Cloitre M, Goldstein M, Engelien A, Yang Y, Gorman J, LeDoux J, Stern E, Silbersweig D (2006) Increased brainstem volume in panic disorder: a voxel-based morphometric study. NeuroReport 17(4):361–363PubMedCrossRef

Radua J, van den Heuvel OA, Surguladze S, Mataix-Cols D (2010) Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders. Arch Gen Psychiatry 67(7):701–711PubMedCrossRef

Rakic P (2009) Evolution of the neocortex: a perspective from developmental biology. Nat Rev Neurosci 10(10):724–735PubMedCrossRef

Reiman EM, Raichle ME, Butler FK, Herscovitch P, Robins E (1984) A focal brain abnormality in panic disorder, a severe form of anxiety. Nature 310(5979):683–685PubMedCrossRef

Reiman EM, Raichle ME, Robins E, Butler FK, Herscovitch P, Fox P, Perlmutter J (1986) The application of positron emission tomography to the study of panic disorder. Am J Psychiatry 143(4):469–477PubMed

Reiman EM, Fusselman MJ, Fox PT, Raichle ME (1989a) Neuroanatomical correlates of anticipatory anxiety. Science 243(4894 Pt 1):1071–1074PubMedCrossRef

Reiman EM, Raichle ME, Robins E, Mintun MA, Fusselman MJ, Fox PT, Price JL, Hackman KA (1989b) Neuroanatomical correlates of a lactate-induced anxiety attack. Arch Gen Psychiatry 46(6):493–500PubMedCrossRef

Roppongi T, Nakamura M, Asami T, Hayano F, Otsuka T, Uehara K, Fujiwara A, Saeki T, Hayasaka S, Yoshida T, Shimizu R, Inoue T, Hirayasu Y (2010) Posterior orbitofrontal sulcogyral pattern associated with orbitofrontal cortex volume reduction and anxiety trait in panic disorder. Psychiatry Clin Neurosci 64(3):318–326PubMedCrossRef

Sakai Y, Kumano H, Nishikawa M, Sakano Y, Kaiya H, Imabayashi E, Ohnishi T, Matsuda H, Yasuda A, Sato A, Diksic M, Kuboki T (2005) Cerebral glucose metabolism associated with a fear network in panic disorder. NeuroReport 16(9):927–931PubMedCrossRef

Sakai Y, Kumano H, Nishikawa M, Sakano Y, Kaiya H, Imabayashi E, Ohnishi T, Matsuda H, Yasuda A, Sato A, Diksic M, Kuboki T (2006) Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive-behavioral therapy. NeuroImage 33(1):218–226PubMedCrossRef

Schlegel S, Steinert H, Bockisch A, Hahn K, Schloesser R, Benkert O (1994) Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report. Eur Arch Psychiatry Clin Neurosci 244(1):49–51PubMedCrossRef

Schunck T, Mathis A, Erb G, Namer IJ, Hode Y, Demazieres A, Luthringer R (2011) One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI. J Psychopharmacol 25(1):52–59PubMedCrossRef

Sehlmeyer C, Dannlowski U, Schoning S, Kugel H, Pyka M, Pfleiderer B, Zwitserlood P, Schiffbauer H, Heindel W, Arolt V, Konrad C (2011) Neural correlates of trait anxiety in fear extinction. Psychol Med 41(4):789–798PubMedCrossRef

Shinoura N, Yamada R, Tabei Y, Otani R, Itoi C, Saito S, Midorikawa A (2011) Damage to the right dorsal anterior cingulate cortex induces panic disorder. J Affect Disord 133(3):569–572PubMedCrossRef

Shioiri T, Kato T, Murashita J, Hamakawa H, Inubushi T, Takahashi S (1996) High-energy phosphate metabolism in the frontal lobes of patients with panic disorder detected by phase-encoded 31P-MRS. Biol Psychiatry 40(8):785–793PubMedCrossRef

Sim HB, Kang EH, Yu BH (2010) Changes in cerebral cortex and limbic brain functions after short-term paroxetine treatment in panic disorder: an [F]FDG-PET pilot study. Psychiatry Investig 7(3):215–219PubMedCrossRef

Sobanski T, Wagner G, Peikert G, Gruhn U, Schluttig K, Sauer H, Schlosser R (2010) Temporal and right frontal lobe alterations in panic disorder: a quantitative volumetric and voxel-based morphometric MRI study. Psychol Med 40(11):1879–1886PubMedCrossRef

Spiegelhalder K, Hornyak M, Kyle SD, Paul D, Blechert J, Seifritz E, Hennig J, Tebartz van Elst L, Riemann D, Feige B (2009) Cerebral correlates of heart rate variations during a spontaneous panic attack in the fMRI scanner. Neurocase 15(6):527–534PubMedCrossRef

Stewart RS, Devous MD Sr, Rush AJ, Lane L, Bonte FJ (1988) Cerebral blood flow changes during sodium-lactate-induced panic attacks. Am J Psychiatry 145(4):442–449PubMed

Tanii H, Nishimura Y, Inoue K, Koshimizu H, Matsumoto R, Takami T, Hara N, Nishida A, Okada M, Kaiya H, Okazaki Y (2009) Asymmetry of prefrontal cortex activities and catechol-O-methyltransferase Val158Met genotype in patients with panic disorder during a verbal fluency task: near-infrared spectroscopy study. Neurosci Lett 452(1):63–67PubMedCrossRef

Tanii H, Nishimura Y, Inoue K, Hara N, Nishida A, Okada M, Imamura A, Kaiya H, Okazaki Y (2010) Frontal lobe dysfunction in panic disorder: a comparison of multichannel near-infrared spectroscopy in monozygotic twins discordant for panic disorder. J Neuropsychiatry Clin Neurosci 22(2):E3–E4PubMed

Trzesniak C, Uchida RR, Araujo D, Guimaraes FS, Freitas-Ferrari MC, Filho AS, Santos AC, Busatto GF, Zuardi AW, Del-Ben CM, Graeff FG, Crippa JA (2010) (1)H magnetic resonance spectroscopy imaging of the hippocampus in patients with panic disorder. Psychiatry Res 182(3):261–265PubMedCrossRef

Tuescher O, Protopopescu X, Pan H, Cloitre M, Butler T, Goldstein M, Root JC, Engelien A, Furman D, Silverman M, Yang Y, Gorman J, LeDoux J, Silbersweig D, Stern E (2011) Differential activity of subgenual cingulate and brainstem in panic disorder and PTSD. J Anxiety Disord 25(2):251–257PubMedCrossRef

Uchida RR, Del-Ben CM, Santos AC, Araujo D, Crippa JA, Guimaraes FS, Graeff FG (2003) Decreased left temporal lobe volume of panic patients measured by magnetic resonance imaging. Braz J Med Biol Res 36(7):925–929PubMedCrossRef

Uchida RR, Del-Ben CM, Busatto GF, Duran FL, Guimaraes FS, Crippa JA, Araujo D, Santos AC, Graeff FG (2008) Regional gray matter abnormalities in panic disorder: a voxel-based morphometry study. Psychiatry Res 163(1):21–29PubMedCrossRef

Uhde TW, Kellner CH (1987) Cerebral ventricular size in panic disorder. J Affect Disord 12(2):175–178PubMedCrossRef

Ursini G, Bollati V, Fazio L, Porcelli A, Iacovelli L, Catalani A, Sinibaldi L, Gelao B, Romano R, Rampino A, Taurisano P, Mancini M, Di Giorgio A, Popolizio T, Baccarelli A, De Blasi A, Blasi G, Bertolino A (2011) Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity. J Neurosci 31(18):6692–6698PubMedCrossRef

van den Heuvel OA, Veltman DJ, Groenewegen HJ, Witter MP, Merkelbach J, Cath DC, van Balkom AJ, van Oppen P, van Dyck R (2005) Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Arch Gen Psychiatry 62(8):922–933PubMedCrossRef

van den Heuvel OA, Mataix-Cols D, Zwitser G, Cath DC, van der Werf YD, Groenewegen HJ, van Balkom AJ, Veltman DJ (2011) Common limbic and frontal–striatal disturbances in patients with obsessive compulsive disorder, panic disorder and hypochondriasis. Psychol Med 41(11):2399–2410PubMedCrossRef

Vythilingam M, Anderson ER, Goddard A, Woods SW, Staib LH, Charney DS, Bremner JD (2000) Temporal lobe volume in panic disorder—a quantitative magnetic resonance imaging study. Psychiatry Res 99(2):75–82PubMedCrossRef

Walker DL, Miles LA, Davis M (2009) Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses. Prog Neuropsychopharmacol Biol Psychiatry 33(8):1291–1308PubMedCrossRef

Wiedemann G, Pauli P, Dengler W, Lutzenberger W, Birbaumer N, Buchkremer G (1999) Frontal brain asymmetry as a biological substrate of emotions in patients with panic disorders. Arch Gen Psychiatry 56(1):78–84PubMedCrossRef

Wiest G, Lehner-Baumgartner E, Baumgartner C (2006) Panic attacks in an individual with bilateral selective lesions of the amygdala. Arch Neurol 63(12):1798–1801

Wise V, McFarlane AC, Clark CR, Battersby M (2011) An integrative assessment of brain and body function ‘at rest’ in panic disorder: a combined quantitative EEG/autonomic function study. Int J Psychophysiol 79(2):155–165

Wittmann A, Schlagenhauf F, John T, Guhn A, Rehbein H, Siegmund A, Stoy M, Held D, Schulz I, Fehm L, Fydrich T, Heinz A, Bruhn H, Ströhle A (2011) A new paradigm (Westphal-Paradigm) to study the neural correlates of panic disorder with agoraphobia. Eur Arch Psychiatry Clin Neurosci 261(3):185–194

Woods SW, Koster K, Krystal JK, Smith EO, Zubal IG, Hoffer PB, Charney DS (1988) Yohimbine alters regional cerebral blood flow in panic disorder. Lancet 2(8612):678PubMedCrossRef

Wurthmann C, Bogerts B, Gregor J, Baumann B, Effenberger O, Dohring W (1997) Frontal CSF enlargement in panic disorder: a qualitative CT-scan study. Psychiatry Res 76(2–3):83–87PubMed

Yoo HK, Kim MJ, Kim SJ, Sung YH, Sim ME, Lee YS, Song SY, Kee BS, Lyoo IK (2005) Putaminal gray matter volume decrease in panic disorder: an optimized voxel-based morphometry study. Eur J Neurosci 22(8):2089–2094PubMedCrossRef

Zhang Y, Duan L, Liao M, Yang F, Liu J, Shan B, Li L (2011) MRI for brain structure and function in patients with first-episode panic disorder. Zhong Nan Da Xue Xue Bao Yi Xue Ban 36(12):1170–1175PubMed

Titel: Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder
Publikationsdatum: 01.01.2013
Erschienen in: Journal of Neural Transmission / Ausgabe 1/2013
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-012-0811-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

Differential adaptation of REM sleep latency, intermediate stage and theta power effects of escitalopram after chronic treatment

Editorial

A systematic review on olfaction in child and adolescent psychiatric disorders

A possible pathophysiological role of tyrosine hydroxylase in Parkinson’s disease suggested by postmortem brain biochemistry: a contribution for the special 70th birthday symposium in honor of Prof. Peter Riederer

Mild cognitive impairment in Parkinson disease: heterogenous mechanisms